Extension of Research Term. The Parties may mutually agree in writing to further extend the Research Program for one (1) or more additional years on terms and conditions to be mutually agreed.
Extension of Research Term. [*] ([*]) days prior to the expiration of the initial Research Term, the JRC shall discuss the possibility of extending the Research Program and correspondingly the Research Term. In such event, if the Parties do not reach agreement on an extension of the Research Term prior to the expiration of the initial Research Term, then the expiration date for the initial Research Team will be extended for [*] ([*]) days, in order to continue negotiation of the terms and conditions for an extension of the Research Term, if any.
Extension of Research Term. Amerimmune may, at its election and after discussing in the JDC, as long as both parties are in mutual agreement, extend the Research Term for up to three (3) one (1) year extension periods (each being a “Research Term Extension”, and each to run consecutively after the end of the then-current Research Term) by giving notice to Amerimmune of each such election at least thirty (30) days prior to the expiration of the then-current Research Term.
Extension of Research Term. Celgene may, at its election, extend the Research Term for a two (2) year extension period (to run consecutively after the end of the then-current Research Term) by giving notice to Vividion of such election at least [***] days prior to the expiration of the then-existing Research Term and by paying the Research Term Extension Fee as set forth in Section 6.3.
Extension of Research Term. With the written agreement of the --------------------------- parties, the Research Term may be extended for up to two (2) years following the Initial Term. If it wishes to extend the Research Term, BMS must notify Pharmacopeia in writing at least six (6) months prior to the then current expiration date for the Research Term. If BMS so notifies Pharmacopeia, the parties shall negotiate in good faith the terms of any such extension.
Extension of Research Term. AZ shall have the right to extend the Research Term on an annual basis for up to [ * ]. To exercise such option, AZ shall so notify Array in writing at least three (3) months prior to the expiration of the Research Term (including any extensions thereof in accordance with this Section 2.7) and the Parties shall enter into good faith discussions as to the required number of Array FTEs for such extension of the Research Term. All such Array FTEs shall be funded by AZ at the FTE rate established under Section 6.2.1 below.
Extension of Research Term. The Parties may mutually agree to extend the Research Term beyond the end of the Initial Research Term for an additional two (2) year period, during which time Sankyo shall fund at least [ * ] FTEs per year at the Annual FTE Rate(s) to be agreed upon by the Parties and such FTEs shall either: (a) [ * ]; or (b) develop [ * ]. If the Parties intend to so extend the Research Term, then at least [ * ] prior to the end of the Initial Research Period, the Parties shall agree upon a written Research Plan that covers such extension period and specifies the applicable Annual FTE Rate(s) and shall amend this Agreement as necessary including, if applicable, to clarify each Parties’ rights and obligations with respect to the [ * ] and [ * ].
Extension of Research Term. The Research Term may be extended by Genentech in accordance with either or both of the provisions set forth in this Section 2.6.
Extension of Research Term. The Research Term may be extended beyond the Initial Research Term on [***], provided that during the Initial Research Term:
Extension of Research Term. Organon shall have the right to further extend the Research Term for additional ***(***) *** periods (the "Extension Term") by giving Ligand written notice at least *** (***) *** before the second anniversary of the Commencement Date with respect to the first such Extension Term and *** (***) *** before the expiration of any subsequent Extension Term; provided, however, that the cummulative Extension Term shall not exceed *** (***) *** unless agreed to by Ligand. The amount paid to Ligand per FTE during any extension shall be in accordance with Section 2.8.
